位置:首页 > 蛋白库 > RENR_DROME
RENR_DROME
ID   RENR_DROME              Reviewed;         320 AA.
AC   Q9VHG4;
DT   18-SEP-2019, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=ATPase H(+)-transporting accessory protein 2 {ECO:0000303|PubMed:29127204, ECO:0000312|FlyBase:FBgn0037671};
DE   AltName: Full=Renin homolog receptor {ECO:0000305};
DE            Short=dPRR {ECO:0000303|PubMed:20579879, ECO:0000312|FlyBase:FBgn0037671};
DE   Contains:
DE     RecName: Full=ATPase H(+)-transporting accessory protein 2 N-terminal fragment {ECO:0000303|PubMed:23292348};
DE   Contains:
DE     RecName: Full=ATPase H(+)-transporting accessory protein 2 C-terminal fragment {ECO:0000303|PubMed:23292348};
DE   Flags: Precursor;
GN   Name=ATP6AP2 {ECO:0000303|PubMed:29127204,
GN   ECO:0000312|FlyBase:FBgn0037671};
GN   Synonyms=VhaM8-9 {ECO:0000312|FlyBase:FBgn0037671},
GN   VhaM8.9 {ECO:0000312|FlyBase:FBgn0037671},
GN   VhaPRR {ECO:0000303|PubMed:20579879, ECO:0000312|FlyBase:FBgn0037671};
GN   ORFNames=CG8444 {ECO:0000312|FlyBase:FBgn0037671};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3] {ECO:0000312|EMBL:AAK93214.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley {ECO:0000312|EMBL:AAK93214.1};
RC   TISSUE=Embryo {ECO:0000312|EMBL:AAK93214.1};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [4] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH FZ AND FZ2, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=20579883; DOI=10.1016/j.cub.2010.05.028;
RA   Buechling T., Bartscherer K., Ohkawara B., Chaudhary V., Spirohn K.,
RA   Niehrs C., Boutros M.;
RT   "Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the
RT   prorenin receptor.";
RL   Curr. Biol. 20:1263-1268(2010).
RN   [5] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20579879; DOI=10.1016/j.cub.2010.05.057;
RA   Hermle T., Saltukoglu D., Gruenewald J., Walz G., Simons M.;
RT   "Regulation of Frizzled-dependent planar polarity signaling by a V-ATPase
RT   subunit.";
RL   Curr. Biol. 20:1269-1276(2010).
RN   [6] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH STAN, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE,
RP   PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF ARG-248 AND ARG-251.
RX   PubMed=23292348; DOI=10.1038/emboj.2012.323;
RA   Hermle T., Guida M.C., Beck S., Helmstaedter S., Simons M.;
RT   "Drosophila ATP6AP2/VhaPRR functions both as a novel planar cell polarity
RT   core protein and a regulator of endosomal trafficking.";
RL   EMBO J. 32:245-259(2013).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26376863; DOI=10.1093/hmg/ddv380;
RA   Dubos A., Castells-Nobau A., Meziane H., Oortveld M.A., Houbaert X.,
RA   Iacono G., Martin C., Mittelhaeuser C., Lalanne V., Kramer J.M., Bhukel A.,
RA   Quentin C., Slabbert J., Verstreken P., Sigrist S.J., Messaddeq N.,
RA   Birling M.C., Selloum M., Stunnenberg H.G., Humeau Y., Schenck A.,
RA   Herault Y.;
RT   "Conditional depletion of intellectual disability and Parkinsonism
RT   candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and
RT   neurodegeneration.";
RL   Hum. Mol. Genet. 24:6736-6755(2015).
RN   [8] {ECO:0000305}
RP   FUNCTION, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, MOTIF, PROTEOLYTIC
RP   CLEAVAGE, AND MUTAGENESIS OF LEU-98; 316-LYS--ASN-320; ARG-248 AND ARG-251.
RX   PubMed=29127204; DOI=10.1084/jem.20170453;
RA   Rujano M.A., Cannata Serio M., Panasyuk G., Peanne R., Reunert J.,
RA   Rymen D., Hauser V., Park J.H., Freisinger P., Souche E., Guida M.C.,
RA   Maier E.M., Wada Y., Jaeger S., Krogan N.J., Kretz O., Nobre S., Garcia P.,
RA   Quelhas D., Bird T.D., Raskind W.H., Schwake M., Duvet S., Foulquier F.,
RA   Matthijs G., Marquardt T., Simons M.;
RT   "Mutations in the X-linked ATP6AP2 cause a glycosylation disorder with
RT   autophagic defects.";
RL   J. Exp. Med. 214:3707-3729(2017).
RN   [9] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH VHAAC45, SUBCELLULAR LOCATION, DISRUPTION
RP   PHENOTYPE, MOTIF, AND MUTAGENESIS OF 299-ALA--ASN-320 AND 317-LYS--ASN-320.
RX   PubMed=29995586; DOI=10.1091/mbc.e18-04-0234;
RA   Guida M.C., Hermle T., Graham L.A., Hauser V., Ryan M., Stevens T.H.,
RA   Simons M.;
RT   "ATP6AP2 functions as a V-ATPase assembly factor in the endoplasmic
RT   reticulum.";
RL   Mol. Biol. Cell 29:2156-2164(2018).
CC   -!- FUNCTION: Multifunctional protein which functions as transmembrane
CC       receptor in the planar cell polarity (PCP) and is involved in the
CC       assembly of the proton-transporting vacuolar (V)-ATPase protein pump
CC       (PubMed:20579883, PubMed:20579879, PubMed:29127204, PubMed:29995586).
CC       As transmembrane receptor mediates fz/PCP signaling through interaction
CC       with fz and stabilizes asymmetric PCP domains through its interaction
CC       with stan (PubMed:20579883, PubMed:20579879, PubMed:23292348,
CC       PubMed:29995586). Also mediates Wnt/beta-cat signaling through
CC       interaction with fz/fz2 (PubMed:20579883, PubMed:20579879). Probably by
CC       controlling the assembly of the V-ATPase pump and thus the
CC       acidification of the endo-lysosomal system, plays a role in many
CC       neuronal processes including synapse morphology and synaptic
CC       transmission (PubMed:26376863). {ECO:0000269|PubMed:20579879,
CC       ECO:0000269|PubMed:20579883, ECO:0000269|PubMed:23292348,
CC       ECO:0000269|PubMed:26376863, ECO:0000269|PubMed:29127204,
CC       ECO:0000269|PubMed:29995586}.
CC   -!- FUNCTION: [ATPase H(+)-transporting accessory protein 2 N-terminal
CC       fragment]: Stabilizes asymmetric Planar Cell Polarity (PCP) domains
CC       through its interaction with stan. {ECO:0000269|PubMed:23292348}.
CC   -!- SUBUNIT: Interacts with fz and fz2 (PubMed:20579883). Interacts (via N-
CC       terminus) with stan (PubMed:23292348). As an accessory component of the
CC       multisubunit proton-transporting vacuolar (V)-ATPase protein pump,
CC       might interacts with VhaAC45 (PubMed:29995586).
CC       {ECO:0000269|PubMed:20579883, ECO:0000269|PubMed:23292348,
CC       ECO:0000269|PubMed:29995586}.
CC   -!- SUBCELLULAR LOCATION: [ATPase H(+)-transporting accessory protein 2]:
CC       Cell membrane {ECO:0000269|PubMed:20579879,
CC       ECO:0000269|PubMed:20579883}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:20579883}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:20579883, ECO:0000269|PubMed:23292348,
CC       ECO:0000269|PubMed:29995586}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:20579883}. Vesicle {ECO:0000269|PubMed:23292348}.
CC       Apical cell membrane {ECO:0000269|PubMed:23292348}; Single-pass type I
CC       membrane protein {ECO:0000269|PubMed:23292348}. Golgi apparatus
CC       membrane {ECO:0000269|PubMed:29995586}; Single-pass type I membrane
CC       protein {ECO:0000269|PubMed:29995586}. Note=Co-localizes at the apical
CC       junctions with stan. {ECO:0000269|PubMed:23292348}.
CC   -!- SUBCELLULAR LOCATION: [ATPase H(+)-transporting accessory protein 2 N-
CC       terminal fragment]: Secreted {ECO:0000269|PubMed:23292348}.
CC       Note=Localization to the planar cell polarity domains depends by stan.
CC       {ECO:0000269|PubMed:23292348}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in whole larval extracts, fat body and
CC       larval brain (PubMed:29127204). At prepupal stages, expressed towards
CC       the wing margin; during the junctional remodeling phase relocalizes to
CC       intracellular compartments; before prehair formation, enriched at P-D
CC       membranes (at protein level) (PubMed:23292348).
CC       {ECO:0000269|PubMed:23292348, ECO:0000269|PubMed:29127204}.
CC   -!- PTM: Proteolytically cleaved by a furin-like convertase in the trans-
CC       Golgi network to generate N- and C-terminal fragments (PubMed:23292348,
CC       PubMed:29127204). Cleavage is reduced in the fat body
CC       (PubMed:29127204). {ECO:0000269|PubMed:23292348,
CC       ECO:0000269|PubMed:29127204}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown is lethal
CC       (PubMed:20579883). RNAi-mediated knockdown in the wings results in
CC       increased apoptosis, endoplasmic reticulum stress and lipid
CC       accumulation (PubMed:20579883, PubMed:20579879, PubMed:29127204,
CC       PubMed:29995586). This is accompanied by severe growth defects
CC       including venation defects, defective wing-hair polarity (as a result
CC       of defective fz and stan trafficking) and wg signaling
CC       (PubMed:20579883, PubMed:20579879, PubMed:29127204, PubMed:29995586).
CC       RNAi-mediated knockdown in the notum causes severe planar polarity
CC       defects affecting orientation morphology and number of sensory bristles
CC       or microchaetae (PubMed:20579879). RNAi-mediated knockdown in the eye
CC       results in defective phototaxis and presynaptic transmission in
CC       vacuolated photoreceptor neurons and pigment cells (PubMed:26376863).
CC       RNAi-mediated knockdown in neurons leads to defective autophagy and
CC       neurodegeneration, impaired synapse morphology, ultrastructural
CC       organization and axonal transport of the active zone component brp,
CC       ultimately resulting in lethality at different developmental stages
CC       (PubMed:26376863). The few adult survivors show strongly reduced
CC       spontaneous movements and poor climbing abilities (PubMed:26376863).
CC       RNAi-mediated knockdown in the mushroom body results in altered
CC       short- and long-term memory (PubMed:26376863). RNAi-mediated knockdown
CC       in the fat body results in increased autophagy (PubMed:29127204).
CC       {ECO:0000269|PubMed:20579879, ECO:0000269|PubMed:20579883,
CC       ECO:0000269|PubMed:26376863, ECO:0000269|PubMed:29127204,
CC       ECO:0000269|PubMed:29995586}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE014297; AAF54350.1; -; Genomic_DNA.
DR   EMBL; AY051790; AAK93214.1; -; mRNA.
DR   RefSeq; NP_649876.1; NM_141619.3.
DR   AlphaFoldDB; Q9VHG4; -.
DR   SMR; Q9VHG4; -.
DR   STRING; 7227.FBpp0081458; -.
DR   PaxDb; Q9VHG4; -.
DR   PRIDE; Q9VHG4; -.
DR   DNASU; 41104; -.
DR   EnsemblMetazoa; FBtr0081978; FBpp0081458; FBgn0037671.
DR   GeneID; 41104; -.
DR   KEGG; dme:Dmel_CG8444; -.
DR   UCSC; CG8444-RA; d. melanogaster.
DR   CTD; 10159; -.
DR   FlyBase; FBgn0037671; ATP6AP2.
DR   VEuPathDB; VectorBase:FBgn0037671; -.
DR   eggNOG; KOG4737; Eukaryota.
DR   GeneTree; ENSGT00390000008856; -.
DR   HOGENOM; CLU_065819_0_0_1; -.
DR   InParanoid; Q9VHG4; -.
DR   OMA; CDINFEQ; -.
DR   OrthoDB; 1179410at2759; -.
DR   PhylomeDB; Q9VHG4; -.
DR   Reactome; R-DME-2022377; Metabolism of Angiotensinogen to Angiotensins.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   SignaLink; Q9VHG4; -.
DR   BioGRID-ORCS; 41104; 0 hits in 1 CRISPR screen.
DR   GenomeRNAi; 41104; -.
DR   PRO; PR:Q9VHG4; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0037671; Expressed in adult hindgut (Drosophila) and 46 other tissues.
DR   GO; GO:0045177; C:apical part of cell; IDA:FlyBase.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030424; C:axon; IEA:GOC.
DR   GO; GO:0009986; C:cell surface; IDA:FlyBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0016471; C:vacuolar proton-transporting V-type ATPase complex; IMP:UniProtKB.
DR   GO; GO:0005109; F:frizzled binding; IDA:FlyBase.
DR   GO; GO:0038023; F:signaling receptor activity; IEA:InterPro.
DR   GO; GO:0098930; P:axonal transport; IMP:FlyBase.
DR   GO; GO:0048749; P:compound eye development; IMP:FlyBase.
DR   GO; GO:0016197; P:endosomal transport; IMP:FlyBase.
DR   GO; GO:0048104; P:establishment of body hair or bristle planar orientation; IMP:FlyBase.
DR   GO; GO:0001737; P:establishment of imaginal disc-derived wing hair orientation; IMP:FlyBase.
DR   GO; GO:0001736; P:establishment of planar polarity; IMP:UniProtKB.
DR   GO; GO:0035317; P:imaginal disc-derived wing hair organization; IMP:FlyBase.
DR   GO; GO:0007616; P:long-term memory; IMP:FlyBase.
DR   GO; GO:0042331; P:phototaxis; IMP:FlyBase.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0090251; P:protein localization involved in establishment of planar polarity; IMP:FlyBase.
DR   GO; GO:1902600; P:proton transmembrane transport; ISS:FlyBase.
DR   GO; GO:0007614; P:short-term memory; IMP:FlyBase.
DR   GO; GO:0050808; P:synapse organization; IMP:FlyBase.
DR   GO; GO:0070072; P:vacuolar proton-transporting V-type ATPase complex assembly; IGI:UniProtKB.
DR   InterPro; IPR012493; Renin_rcpt.
DR   PANTHER; PTHR13351; PTHR13351; 1.
DR   Pfam; PF07850; Renin_r; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cleavage on pair of basic residues; Endoplasmic reticulum;
KW   Golgi apparatus; Membrane; Receptor; Reference proteome; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..320
FT                   /note="ATPase H(+)-transporting accessory protein 2"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5015100291"
FT   CHAIN           18..248
FT                   /note="ATPase H(+)-transporting accessory protein 2 N-
FT                   terminal fragment"
FT                   /evidence="ECO:0000269|PubMed:23292348"
FT                   /id="PRO_0000447860"
FT   CHAIN           252..320
FT                   /note="ATPase H(+)-transporting accessory protein 2 C-
FT                   terminal fragment"
FT                   /evidence="ECO:0000269|PubMed:23292348"
FT                   /id="PRO_0000447861"
FT   TOPO_DOM        18..277
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        278..298
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        299..320
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   MOTIF           317..320
FT                   /note="Mediates retrograde transport to the ER"
FT                   /evidence="ECO:0000269|PubMed:29127204,
FT                   ECO:0000269|PubMed:29995586"
FT   SITE            248..249
FT                   /note="Cleavage; by furin-like protease"
FT                   /evidence="ECO:0000269|PubMed:23292348,
FT                   ECO:0000269|PubMed:29127204"
FT   SITE            251..252
FT                   /note="Cleavage; by furin-like protease"
FT                   /evidence="ECO:0000269|PubMed:23292348,
FT                   ECO:0000269|PubMed:29127204"
FT   MUTAGEN         98
FT                   /note="L->S: Reduces protein stability and increases N-
FT                   glycosylation levels of proteins which targets the
FT                   misfolded protein to degradation. Impairs autophagy and
FT                   mTOR signaling. Reduces eclosion rate with few adult
FT                   escapers showing poor mobility, decreased or absent
FT                   climbing capabilities, blistered winds and reduced size and
FT                   death within 3-4 days. In the brain, results in neural
FT                   development defects in the optic lobe. In the fat body,
FT                   increases lipid droplets size and total triglycerides."
FT                   /evidence="ECO:0000269|PubMed:29127204"
FT   MUTAGEN         248
FT                   /note="R->A: Prevents cleavage; when associated with A-
FT                   251."
FT                   /evidence="ECO:0000269|PubMed:23292348,
FT                   ECO:0000269|PubMed:29127204"
FT   MUTAGEN         251
FT                   /note="R->A: Prevents cleavage; when associated with A-
FT                   248."
FT                   /evidence="ECO:0000269|PubMed:23292348,
FT                   ECO:0000269|PubMed:29127204"
FT   MUTAGEN         299..320
FT                   /note="Missing: Lethal in the late larval stage with few
FT                   adult escapers showing poor mobility, decreased or absent
FT                   climbing capabilities, blistered wings, reduced head size
FT                   and death within 3-4 days after eclosion. Impairs
FT                   localization to the endoplasmic reticulum, enhances
FT                   cleavage and protein stability."
FT                   /evidence="ECO:0000269|PubMed:29127204,
FT                   ECO:0000269|PubMed:29995586"
FT   MUTAGEN         317..320
FT                   /note="Missing: Survive till late pupal stage. Impairs
FT                   localization to the endoplasmic reticulum and autophagy
FT                   degradation. In the fat body, increases lipid droplets size
FT                   and total triglycerides."
FT                   /evidence="ECO:0000269|PubMed:29127204,
FT                   ECO:0000269|PubMed:29995586"
SQ   SEQUENCE   320 AA;  34421 MW;  401BCEAAA4FBA7E5 CRC64;
     MLRVFVIFSL FIAAINASGE FTVLNRPKAI SFKGNDALES HYVGDVLYAS MGNAVSGDTN
     WNGLTINDPF NLAKGVILVH VQGIGHVTTA GNVKTYELTG SGTDASLNAL AAELEAANEP
     VCDINFEQFD DGVQAWKSCF GDFEAPAAKP TKHLNPSLHT ADKQFLQEVG FINSAADHLA
     EMAKPSNVLM LRVSVDGVAK AHGEKSVAVE EANKLLSAAI SRLLAASQKS SDSVLFVQTT
     EKDVAASRAK RDTIAASTTN PYNLAVYYGS DYPVIFNIIL WFMVVFGLSL LAICYAIAAM
     DPGRDSIIYR MTSTRIKKDN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024